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Abstract
The activation of host cells by interferon gamma (IFNc) is essential for inhibiting the intracellular replication of most
microbial pathogens. Although significant advances have been made in identifying IFNc-dependent host factors that
suppress intracellular bacteria, little is known about how IFNc enables cells to recognize, or restrict, the growth of
pathogens that replicate in the host cytoplasm. The replication of the cytosolic bacterial pathogen Shigella flexneri is
significantly inhibited in IFNc-stimulated cells, however the specific mechanisms that mediate this inhibition have remained
elusive. We found that S. flexneri efficiently invades IFNc-activated mouse embryonic fibroblasts (MEFs) and escapes from
the vacuole, suggesting that IFNc acts by blocking S. flexneri replication in the cytosol. This restriction on cytosolic growth
was dependent on interferon regulatory factor 1 (IRF1), an IFNc-inducible transcription factor capable of inducing IFNc-
mediated cell-autonomous immunity. To identify host factors that restrict S. flexneri growth, we used whole genome
microarrays to identify mammalian genes whose expression in S. flexneri-infected cells is controlled by IFNc and IRF1.
Among the genes we identified was the pattern recognition receptor (PRR) retanoic acid-inducible gene I (RIG-I), a
cytoplasmic sensor of foreign RNA that had not been previously known to play a role in S. flexneri infection. We found that
RIG-I and its downstream signaling adaptor mitochondrial antiviral signaling protein (MAVS)—but not cytosolic Nod-like
receptors (NLRs)—are critically important for IFNc-mediated S. flexneri growth restriction. The recently described RNA
polymerase III pathway, which transcribes foreign cytosolic DNA into the RIG-I ligand 59-triphosphate RNA, appeared to be
involved in this restriction. The finding that RIG-I responds to S. flexneri infection during the IFNc response extends the
range of PRRs that are capable of recognizing this bacterium. Additionally, these findings expand our understanding of how
IFNc recognizes, and ultimately restricts, bacterial pathogens within host cells.
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Introduction
Shigella flexneri is a Gram-negative bacterial pathogen that causes
bacillary dysentery, resulting in significant morbidity and mortality
worldwide. Following ingestion, S. flexneri translocate through the
colonic epithelial cell barrier, where they infect resident macro-
phages and rapidly induce caspase-1-dependent pyroptotic cell
death in these cells [1,2,3]. After escaping from the dying
macrophages, S. flexneri invade nearby colonic epithelial cells
using a Type III secretion system (TTSS) and become temporarily
enclosed within a membrane-bound vacuole. The bacteria rapidly
escape from the vacuole using a poorly defined mechanism and
enter the host cytoplasm, where they engage in both intra- and
inter- cellular motility by inducing local actin polymerization at
one pole of the bacterium [4]. Invasion, vacuole escape, and
intercellular spreading augment the dissemination of S. flexneri
throughout the epithelium. Simultaneously, however, these
virulence mechanisms also inadvertently allow greater recognition
of the bacterium by the host through various intracellular
immunosurveillance pathways. The stimulation of these immuno-
surveillance pathways ultimately leads to the induction of a robust
proinflammatory response and the eventual resolution of infection
[5,6,7,8].
A critical mediator of the proinflammatory response to S. flexneri
is the cytokine IFNc (also known as Type II IFN), which acts on a
wide variety of cells types to regulate the expression of over 2,000
genes [9]. In the past decade, significant progress has been made
in identifying and characterizing the downstream IFNc-inducible
intracellular resistance mechanisms that coordinate the killing or
growth inhibition of microbial pathogens. Some of these
mechanisms include the targeting of bactericidal reactive oxygen
species (ROS) to pathogen containing vacuoles (PCVs), the direct
vesiculation and destruction of PCVs [10,11,12,13], and the
induction of antimicrobial autophagy [14]. Although advances
have been made in identifying IFNc-inducible intracellular
resistance mechanisms, the mechanisms responsible for restricting
many cytosolic bacterial pathogens have largely remained elusive,
presumably a result of redundancy among effector mechanisms.
One study found that Francisella tularensis escapes to the cytosol of
IFNc-activated primary macrophages but is subsequently restrict-
ed for cytosolic growth by an unknown mechanism, independently
of reactive nitrogen species (RNS) or ROS [15]. However, a
parallel study found that inhibition of RNS was able to block F.
tularensis killing but did not restore intracellular replication [16]. In
contrast, the cytosolic pathogen Listeria monocytogenes fails to escape
the phagosome and is subsequently killed in IFNc-activated
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hemolysin listeriolysin O (LLO) by RNS and ROS [17,18].
The importance of IFNc in host defense during S. flexneri
infection was demonstrated by Way, et al., who showed that the
lethal dose of S. flexneri is 5 logs greater in immunocompetent mice
compared to IFNc
2/2 mice [9]. Furthermore, immunocompetent
mice challenged with 10
5 CFU of S. flexneri were able to clear the
infection by 5 days post infection, while IFNc
2/2 mice were
unable to inhibit S. flexneri replication and eventually succumbed to
the infection. The effect of IFNc on cell autonomous resistance to
S. flexneri has also been demonstrated. Primary mouse macro-
phages or rat L2 fibroblasts pre-treated with IFNc prior to
infection significantly inhibit S. flexneri growth compared to
untreated cells [9]. Although IFNc is a critical mediator of innate
immunity against this bacterium, the IFNc-inducible host factors
mediating cell autonomous resistance against this bacterium are
completely unknown. Moreover, unlike F. tularensis and L.
monocytogenes, no data are available on the specific step of S. flexneri
pathogenesis that is blocked by IFNc in macrophages or in other
cell types also naturally infected by this bacterium, such as non-
myeloid epithelial cells.
Here we sought to identify which step of S. flexneri intracellular
infection is inhibited in IFNc-activated non-myeloid cells and to
begin to define the cellular mechanism(s) and pathways that are
enabled by IFNc to recognize or restrict intracellular S. flexneri
infection. We found that S. flexneri efficiently invades and escapes
from the vacuole of IFNc-activated MEFs and are inhibited at the
step of cytosolic replication. Furthermore, we found that the
detection of S. flexneri infection by the cytoplasmic RNA sensor
RIG-I was required for the inhibition of S. flexneri cytosolic growth
by IFNc. Interestingly, S. flexneri genomic DNA and RNA were
sufficient to induce RIG-I dependent immune responses. Addi-
tionally, chemical inhibition of host RNA polymerase III partially
blocked the ability of IFNc to inhibit S. flexneri growth, suggesting
that S. flexneri DNA is a stimulus of the IFNc-dependent immune
response against this bacterium. Collectively, these findings
implicate the RIG-I/MAVS signaling pathway as a crucial
component of cell autonomous IFNc-mediated restriction of
cytosolic bacterial pathogens.
Results
IFNc restricts the cytosolic replication of S. flexneri in
MEFs
The replication of S. flexneri within the colonic epithelium is an
essential determinant of this bacterium’s pathogenesis. Previously
it was demonstrated that IFNc inhibits the growth of this
bacterium in both mouse macrophages and rat L2 fibroblasts
[9]. To determine how IFNc might inhibit the intracellular growth
of this bacterium in the epithelium, we examined S. flexneri growth
in mouse primary MEFs, as a model for non-myeloid epithelial
cells. While unstimulated MEFs were highly permissive for S.
flexneri replication over a 15 hour infection, pre-stimulation of
MEFs with IFNc prior to infection drastically inhibited bacterial
growth by 15 hours post infection (hpi) (Fig. 1A). Interestingly, S.
flexneri grew similarly well in unstimulated and IFNc-stimulated
cells for at least 5 hpi, indicating that the antimicrobial mecha-
nisms that block S. flexneri growth are not immediately felt by the
bacteria. The addition of IFNc to the cell culture media only at the
time of the infection had no effect on S. flexneri growth (data not
shown), suggesting that IFNc-mediated priming of the cell prior to
infection is necessary for the restriction.
Invasion of host cells and vacuolar escape by S. flexneri are
essential for the evasion of extracellular and intracellular immune
mechanisms, respectively. An intriguing hypothesis to explain the
ability of IFNc to inhibit intracellular S. flexneri is that this cytokine
affects a specific stage of the bacterium’s intracellular pathogenic
cycle to prevent otherwise efficient escape from antimicrobial
mechanisms. While a non-invasive virulence plasmid-cured strain
of S. flexneri was over 100-fold less invasive than the wild-type (WT)
strain, WT S. flexneri invaded unstimulated and IFNc-stimulated
cells with similar efficiencies (Fig. 1B). Many vacuolar– and even
cytosolic– pathogens are killed in IFNc-activated cells following
invasion by mechanisms targeting nascent pathogen containing
vacuoles formed during microbial invasion or uptake [18].
Therefore, one possibility was that IFNc-induced mechanisms
either destroy S. flexneri in the vacuole prior to vacuole escape or
functionally disrupt the action of bacterial effectors necessary for
vacuole escape. To assess the ability of S. flexneri to escape from the
vacuole of IFNc-activated MEFs, unstimulated and stimulated
cells were infected for 30 minutes and subsequently treated with
chloroquine, which concentrates in phagosomes of host cells at
bactericidal levels. As expected, the plasmid-cured strain (which is
deficient for vacuole escape) was killed in the presence of
chloroquine, confirming that chloroquine effectively killed bacteria
trapped in the vacuole. Interestingly, similar numbers of bacteria
were recovered from unstimulated and stimulated MEFs both in
the absence and presence of chloroquine, suggesting that S. flexneri
efficiently escapes to the cytoplasm of IFNc-treated cells (Fig. 1C).
Collectively these findings demonstrate that S. flexneri enters into
cells and accesses the cytoplasm of IFNc-activated MEFs,
demonstrating that inhibition occurs after the organisms reach
the cytoplasm.
Once in the host cytoplasm, S. flexneri becomes motile and
spreads to adjacent cells through the activity of IcsA, a bacterial
cell surface-associated protein required for the polymerization of
host actin in the cytoplasm [19,20]. Since access to the cell
cytoplasm is a prerequisite for actin tail formation, we examined
the ability of S. flexneri to form actin tails at 2 hpi to confirm that S.
flexneri reaches the cytoplasm of IFNc-activated cells. S. flexneri
formed actin tails in both untreated and IFNc-treated cells with
comparable frequency (30% and 26%, respectively) (Fig. 1D),
confirming their presence within the cytoplasm. Although IFNc
did not inhibit the intracellular motility of S. flexneri at early time
Author Summary
Shigella flexneri, the major cause of bacillary dysentery
worldwide, invades and replicates within the cytoplasm of
intestinal epithelial cells, where it disseminates to neigh-
boring cells and ultimately increases the likelihood of
transmission to uninfected hosts. A hallmark of the
mammalian immune system is its ability to inhibit the
growth of such intracellular pathogens by upregulating
intracellular resistance mechanisms in response to the
cytokine IFNc. We found that in non-myeloid host cells
stimulated with IFNc S. flexneri remains able to invade the
cells efficiently and gain access to the host cytoplasm.
Once in the cytoplasm of IFNc-activated cells, the RIG-I/
MAVS immunosurveillance pathway is activated, enabling
the stimulated host cells to inhibit S. flexneri replication.
Interestingly, RIG-I only played a minor role in the cellular
response to this pathogen in the absence of IFNc,
suggesting that the IFNc response ensures the recognition
of the infection through an immunosurveillance pathway
that is otherwise dispensable for controlling S. flexneri
growth. Together, these findings implicate the RIG-I
pathway as a crucial component in the cellular response
to this devastating bacterial pathogen.
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move might be more easily targeted by potential IFNc-induced
mechanisms and therefore be more susceptible to IFNc-mediated
killing. To test this hypothesis, we examined the survival of the
non-motile S. flexneri icsA mutant, which is fully invasive but
deficient for actin tail polymerization and motility [21]. We found
that the icsA strain was more restricted for growth compared to the
WT strain in unstimulated MEFs at 15 hpi, suggesting that non-
motile S. flexneri are more efficiently targeted by IFNc-independent
mechanisms (Fig. 1E). Additionally, like the WT strain, DicsA was
significantly inhibited by IFNc stimulation. However, when these
data were normalized against the observed IFNc-independent
killing (CFU recovered from IFNc-stimulated cells/CFU recov-
ered from unstimulated cells), icsA was not more susceptible to
IFNc-mediated killing compared to the WT strain (8% icsA versus
2% WT recovered from IFNc-treated cells over untreated cells).
This suggests that the mechanisms that inhibit S. flexneri replication
during the IFNc response are not specifically targeted to non-
motile bacteria. The finding that icsA is significantly inhibited by
IFNc also indicates that inhibition of S. flexneri occurs intracellu-
larly, by a mechanism that does not depend on the escape or
spreading of S. flexneri to the extracellular space or to other cells.
Collectively, these experiments demonstrate that, in non-myeloid
cells, S. flexneri growth is inhibited by IFNc following bacterial
invasion and vacuolar escape, at the stage of cytosolic replication.
Restriction of S. flexneri growth by IFNc is dependent on
IRF1
Although previous reports had established the ability of IFNc to
inhibit S. flexneri growth [9], the cellular mechanisms responsible
for this resistance remained completely undefined. One major
component downstream of IFNc signaling that is often required
for microbial inhibition by IFNc is the transcription factor
Figure 1. IFNc inhibits the replication of S. flexneri in the host cytoplasm. (A) Growth of S. flexneri in MEFs that were unstimulated or
stimulated with IFNc for 24 hours prior to infection. (B) Quantification of S. flexneri invasion at 1 hpi. (C) Quantification of S. flexneri vacuole escape.
Unstimulated or IFNc-stimulated cells were infected and subsequently treated with gentamicin alone or gentamicin and choloroquine (50 mg/ml), as
indicated. Bacterial CFU were determined at 2 hpi. (D) Fluorescence micrographs showing actin tail formation by S. flexneri. Unstimulated or IFNc-
stimulated MEFs were infected with GFP-expressing S. flexneri (green) and stained for host cell actin (red) at 2 hpi. White arrows indicate actin tails.
Data for quantification of actin tail formation was gathered from at least 50 infected cells per condition, for 2 independent experiments. (E) Growth of
WT or non-motile icsA in unstimulated or IFNc-stimulated MEFs. MEFs were infected with WT or icsA S. flexneri, and CFU were determined at 15 hpi.
(F) Normalization of CFU in IFNc-stimulated cells for infections with different strains. CFU recovered from IFNc-stimulated cells for each strain were
normalized against CFU recovered from unstimulated cells. All data shown (A–C, E–F) are means and standard deviations. Experiments are
representative experiments from 3 (A, B) or 2 (C–F) independent experiments. Where appropriate, significant statistical differences are indicateda s
follows: ns, not significant; *, p,0.05; **, p,0.005 (Student’s t test). Unless indicated otherwise, noted statistical differences are between
unstimulated and IFNc-stimulated cells for each condition.
doi:10.1371/journal.ppat.1002809.g001
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of transcription factors, which play broad roles in immunity,
oncogenesis, and apoptosis [22,23,24]. IFNc signaling induces the
direct transcriptional upregulation of IRF1 and other genes
containing gamma-activated-site (GAS) elements in their promot-
ers [25]. IRF1 then translocates to the host cell nucleus, where it
binds to interferon stimulated response elements (ISREs) of IFN-
stimulated genes (ISGs) and induces a second wave of IFNc-
dependent gene transcription. Although IFNc-dependent patho-
gen restriction can occur independently of IRF1, this second wave
of transcription induced by IRF1 is often required for IFNc-
mediated growth restriction. To begin to define the cellular
pathways and/or gene products that inhibit S. flexneri replication in
MEFs, we first tested whether IRF1 is induced by IFNc during
infection and whether IRF1 contributes to IFNc-mediated
restriction of this bacterium. We found that IRF1 gene expression
was highly induced by IFNc in uninfected cells, as reported
previously (Fig. 2A). Interestingly, S. flexneri partially inhibited the
ability of IFNc to upregulate IRF1, even though S. flexneri alone
induced the upregulation of IRF1 10-fold compared to unstimu-
lated uninfected cells. We next compared S. flexneri growth in WT
and Irf1
2/2 MEFs to determine whether IRF1 was required for
IFNc-mediated growth restriction of S. flexneri. Although an IFNc-
independent effect of IRF1 on S. flexneri replication was not
observed, IRF1 significantly contributed to the restriction of S.
flexneri growth in IFNc-activated cells by 15 hpi (Fig.2B),
confirming the role of IRF1 in the innate immune response to
this pathogen.
Since IRF1 is required for IFNc-mediated restriction of S.
flexneri, we hypothesized that an effector mechanism downstream
of IRF1-dependent transcription was ultimately required for the
inhibition of S. flexneri growth. Therefore, we used transcriptional
profiling to identify genes that are regulated by IFNc and
dependent on IRF1. Although the identification of IRF1 target
genes by microarray analysis has previously been conducted in
mouse peritoneal macrophages [26], our goal was to identify genes
induced by IFNc in MEFs specifically during S. flexneri infection.
We reasoned that IFNc-inducible gene products that inhibit S.
flexneri growth might require the cooperation of S. flexneri-specific
pathogen-associated molecular pattern (PAMP)-mediated signal-
ing in addition to IFNc for their induction. WT and IRF1
2/2
MEFs were stimulated with IFNc or left unstimulated, and all of
the cells were subsequently infected with WT S. flexneri for 6 hours
before total RNA was harvested. Affymetrix mouse whole genome
microarrays, representing approximately 20,000 genes, were used
to identify IFNc-dependent, IRF1 target genes. Analysis of the
data from unstimulated and IFNc-stimulated WT MEFs revealed
that 365 genes were induced and 100 genes were weakly repressed
more than 2-fold by IFNc during S. flexneri infection (Fig. 3A).
IFNc-altered genes included many well-described IFNc-depen-
dent genes, such as Stat1, chemokines including Cxcl16 and Cxcl9,
anti-viral genes Oasl1, Mx1, and Rsad2, members of the GBP
family Gbp2,- 3, and -6, as well as several previously uncharacter-
ized genes (Table S1). To next identify IFNc-inducible genes that
were dependent on IRF1, we analyzed expression profiles of
IFNc-regulated genes (those identified as altered in Fig. 3A) from
IFNc-stimulated WT cells and IFNc-stimulated IRF1
2/2 cells
(Fig. 3B). We found that 174, or almost half, of the IFNc-
dependent genes were induced and 17 were repressed by IRF1
(Table S2). This is similar to what was found in peritoneal
macrophages in which 387/1,009 IFNc-induced genes were
dependent on IRF1 [26]. The reduction in absolute number of
IFNc-dependent and IFNc- IRF1-dependent genes identified in
our microarray experiments is consistent with previous findings
demonstrating that the IFNc-dependent response in macrophages
is more robust than in MEFs [27]. Microarray data from these
experiments are available in the ArrayExpress database (www.ebi.
ac.uk/arrayexpress) under accession number E-MTAB-713.
The cytosolic RNA sensing RIG-I/MAVS pathway is
required for IFNc-mediated growth restriction of S.
flexneri
Ultimately, we were interested in identifying IFNc-induced,
IRF1-dependent genes capable of blocking S. flexneri growth. As we
began to think about how to prioritize testing genes identified from
the microarray analysis, we first considered our finding that S.
flexneri growth was not significantly inhibited by IFNc until at least
5 hpi (Fig. 1A). We hypothesized that this delay in growth
restriction might correlate with the amount of time that it would
take for full transcriptional or post-transcriptional activation of
important antimicrobial genes that require both IFNc and a signal
transmitted to the cell following infection. In support of this
hypothesis, we found that blocking host protein synthesis with
Figure 2. Restriction of S. flexneri growth by IFNc is dependent
on IRF1. (A) Analysis of Irf1 expression by RT-PCR in WT MEFs. MEFs
were stimulated with IFNc for 24 hours or left unstimulated and
subsequently infected with WT S. flexneri for 6 hours, or left uninfected.
Irf1 transcripts were normalized against host 18S RNA and are shown as
means of triplicate samples. (B) Quantification of WT S. flexneri CFU in
WT or Irf1
2/2 MEFs. Data are representative of at least 3 independent
experiments. Significant statistical differences are indicated as follows:
ns, not significant; *, p,0.05; **,p,0.005 (Student’s t test). Unless
indicated otherwise, noted statistical differences are between unstimu-
lated and IFNc-stimulated cells for each condition.
doi:10.1371/journal.ppat.1002809.g002
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tional elongation, 1 hour prior to the infection (but, importantly,
after IFNc stimulation) blocked the ability of IFNc to inhibit S.
flexneri growth in a dose dependent manner (Fig. 4A). Although
continued IFNc-mediated gene induction would also be blocked
following CHX treatment, the robust expression of IFNc-
dependent, infection-independent genes would have been strongly
upregulated prior to treatment with CHX. These data support the
hypothesis that IFNc-dependent restriction absolutely requires a
transcriptional event after infection.
PRRs, which induce changes in gene transcription following the
detection of conserved microbial products, would be prime
candidates for linking pathogen detection to IFNc-induced
antimicrobial restriction. The Toll-like receptors (TLRs) form
one class of PRRs that are expressed at the cell surface or inside of
endocytic vesicles and recognize microbial components derived
from the extracellular space. Although TLRs are crucial for the
detection of most pathogens, the detection of microbial products in
the host cytosol requires the action of NLRs and RIG-I-like
receptors (RLRs). Cytoplasmic nucleotide-binding oligomerization
domain-containing protein 1 (Nod1) and Nod 2 of the NLR family
recognize specific structures within peptidoglycan, leading to the
recruitment of the adaptor molecule receptor-interacting serine/
threonine protein kinase 2 (RIP2) and subsequent RIP2-dependent
MAPK and NF-kB activation [28], or RIP2-independent recruit-
ment of autophagsomes at sites of bacterial invasion [29]. The
cytoplasmic RLRs RIG-I and melanoma differentiation-associated
antigen 5 (MDA5) belong to the phylogenetically conserved
DExD/H box family of RNA helicases that recognize various
RNA species in the host cytoplasm. Ligand recognition by RIG-I
leads to conformational changes that facilitates its association with
the downstream signaling adaptor MAVS (also known as VISA,
Cardif, IPS-1) at mitochondria and peroxisomes [30,31]. This
interaction results in both the activation of NF-kB and the
phosphorylation of IRF-3, leading to the induction of intracellular
antimicrobial gene expression and the secretion of type I IFNs,
such as IFNb. To identify a potential PRR that might be required
for IFNc-mediated restriction of S. flexneri, we examined the data
from our gene expression experiments for PRRs and/or associated
signaling adaptor molecules that were identified as IFNc-
dependent, IRF1-dependent genes. Genes encoding several PRRs
were highly induced by IFNc during S. flexneri infection and were
dependent on IRF1, including the TLRs TLR2 and TLR3 and
the RLRs RIG-I (encoded by Ddx58) and MDA5 (encoded by
Ifih1) (Fig. 4B). Since the IFNc-mediated inhibition of S. flexneri
occurs in the host cytoplasm, we first focused on the cytosolic
RLRs to determine if these molecules play a role in inhibiting S.
flexneri growth. Additionally, RLRs were interesting because they
had not previously been implicated during S. flexneri infection.
Consistent with our microarray data, it has previously been
reported that RIG-I can be induced by IFNc and is a target gene
of IRF1, due to a single IRF1 binding site in its proximal promoter
[32,33,34]. To determine if RIG-I plays a role in restricting S.
flexneri during the IFNc response, we analyzed bacterial growth in
WT and Ddx58
2/2 (referred to as Rig-I
2/2 for clarity) MEFs.
Surprisingly, we found that RIG-I was critical for the ability of
IFNc to inhibit S. flexneri growth at 15 hpi (Fig. 4C). Interestingly,
RIG-I was also important for IFNc-independent inhibition of this
bacterium at 5 hpi, although it was completely dispensable by
15 hpi. To determine if we could observe a requirement for RIG-I
in IFNc-mediated restriction of a different pathogen that is both
restricted by IFNc and activates the RIG-I pathway, we examined
the growth of L. pneumophila in IFNc-stimulated MEFs but failed to
observe an IFNc-dependent effect of RIG-I (Fig. S1).
Although S. flexneri has been shown to activate members of both
the TLR and NLR families [1,5,6,35], a role for RLRs during S.
flexneri infection had not previously been demonstrated. Addition-
ally, the requirement for RIG-I in the cell autonomous inhibition
of bacterial growth downstream of IFNc signaling had not been
previously described. To determine whether RIG-I-dependent
IFNc-mediated restriction of S. flexneri occurs via the canonical
RIG-I signaling pathway, we next examined S. flexneri growth in
WT and Mavs
2/2 MEFs. MAVS, the downstream signaling
adaptor for RIG-I, was critically important for IFNc-dependent
growth restriction of S. flexneri (Fig. 4D), demonstrating that RIG-I
functions as a signaling molecule acting through its canonically
described pathway during S. flexneri infection, and not as a MAVS-
independent effector of bacterial growth. Interestingly, the
requirement for RIG-I and MAVS for S. flexneri growth inhibition
Figure 3. Comparative expression of transcripts from WT and
Irf1
2/2 MEFs. As indicated, cells were stimulated with IFNc for
18 hours or left unstimulated. All cells were subsequently infected with
S. flexneri for 6 hours prior to extraction of RNA. (A) Scatter plot of
fluorescence intensities of probe sets from unstimulated and IFNc-
stimulated WT MEFs during infection. Dots represent data from
individual probe sets and are plotted as normalized, log-2 transformed
values. Outer diagonal lines indicate 2-fold differences (p,0.05,
ANOVA) in gene expression of a given probe set between different
conditions. All probe sets passing minimum threshold conditions
during analysis are shown in the plot (see Materials and Methods). (B)
Scatter plot of fluorescence intensities of probe sets from IFNc-
stimulated WT and IFNc-stimulated Irf1
2/2 MEFs during infection. Probe
sets shown in panel B are a subset of the total probe sets shown in
panel A and represent only IFNc-dependent genes that were identified
in A. Outer diagonal lines indicate 2-fold differences (p,0.05) in gene
expression of a given probe set between different conditions.
Microarray data shown are from one experiment out of 2 independent
experiments.
doi:10.1371/journal.ppat.1002809.g003
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which IFNc-dependent killing appeared to occur independently of
both RIG-I and MAVS (Fig. S2).
To determine whether other well-described PRR pathways
might similarly play a role in blocking S. flexneri replication
downstream of IFNc, we tested the role of the NLR signaling
adaptor RIP2, as well as Nod1, which is known to inhibit S. flexneri
growth independently of RIP2 [29]. Nod1
2/2 and Rip2
2/2 MEFs
were more permissive for S. flexneri growth compared to WT cells,
both in the absence and presence of IFNc (Fig. 4E). However, in
contrast to RIG-I, these proteins were found to be completely
dispensable for IFNc-dependent restriction of this bacterium after
normalizing for the IFNc-independent effects (Fig. 4F). In fact,
RIP2
2/2 MEFs were slightly more efficient than WT MEFs in
IFNc-induced restriction of S. flexneri growth (0.2% versus 0.6%
CFU recovered in IFNc-stimulated/unstimulated cells, respec-
tively). In addition to cell-autonomous growth restriction, stimu-
lation of some NLR family members can mediate the induction of
the caspase-1 inflammasome in response to microbial infection,
leading to the secretion of proinflammatory cytokines, cell death,
and the restriction of bacterial replication. However, we found that
IFNc-induced restriction of S. flexneri occurred completely
Figure 4. RIG-I and its downstream signaling adaptor MAVS are critical for IFNc-mediated growth restriction of S. flexneri. (A) Host
protein synthesis is important for IFNc-mediated S. flexneri growth restriction. MEFs were stimulated with IFNc for 24 hours or left unstimulated prior
to infection. One hour prior to infection, cycloheximide was added at indicated concentrations. Intracellular CFU was determined at 15 hpi. S. flexneri
invasion into host cells was equivalent under all conditions (not shown). (B) Heat map of intensity signals for selected genes under indicated
conditions. Gene colors correspond to log2-transformed signal intensities from normalized expression data, indicated by the color key. (C, D)
Quantification of S. flexneri CFU in indicated MEF cells infected at an MOI of 1:1. (E, G) Quantification of S. flexneri CFU in indicated MEF cells infected
at an MOI of 1:1 for 15 hours. Invasion was equivalent under all conditions (data not shown). (F) Normalization of S. flexneri growth inhibition by IFNc
in WT, Nod1
2/2 and Rip2
2/2 MEFs. CFU recovered from IFNc-treated cells for each cell line were normalized against CFU recovered from untreated
cells. All data shown are means and standard deviations. Where appropriate, significant statistical differences are indicated as follows: ns, not
significant; *, p,0.05; **,p,0.005 (Student’s t test). Unless indicated otherwise, noted statistical differences are between unstimulated and IFNc-
stimulated cells for each condition.
doi:10.1371/journal.ppat.1002809.g004
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inflammasome induction was also not required (data not shown).
In contrast to Nod1 and RIP2, the TLR signaling adaptor MyD88
contributed to, but was not required for, the ability of IFNc to
block S. flexneri replication (Fig. 4G). Unlike the finding for RIG-I,
this result was partially expected, since MyD88 has been shown to
be important for TLR-independent IFNc signaling [36] and for
the translocation of IRF1 to the nucleus, at least in myeloid
dendritic cells [37]. From our findings, it is unclear whether the
role of MyD88 here is solely attributable to one of these previously
described functions of MyD88 in IFNc-mediated signaling or to an
alternate mechanism, such as an adaptor of TLR signaling.
PRR-mediated detection of microbial pathogens, including S.
flexneri, often results in the transcriptional induction and subse-
quent secretion of type I IFNs, such as IFNb, by the host cell [38].
Therefore, the analysis of type I IFN production can be used to
assess the cellular immune response to a microbial challenge. To
further investigate the role of RIG-I in the cellular immune
response to S. flexneri, we analyzed IFNb production from
uninfected and S. flexneri-infected cells under IFNc-stimulating
conditions. To quantify the bioactivity of IFNb secreted from
infected cells, supernatants from the cells were collected and added
to cells that harbor an IFNb-dependent luciferase reporter (L929-
ISRE cells) as described previously [39]. While supernatants from
quiescent uninfected WT and Rig-I
2/2 cells activated the reporter
cells with a comparably low efficiency, supernatants from cells
transfected with the known RIG-I ligand low molecular weight
(LMW) poly (I:C),a synthetic analog of dsRNA, significantly
induced the activation of the reporter cells, and this effect was
partially dependent on RIG-I (Fig. 5A). Supernatants from
unstimulated cells infected with S. flexneri for 8 hours also activated
the reporter cells over uninfected cells, but this activation was not
dependent on RIG-I. Interestingly, S. flexneri-mediated induction
of IFNb secretion was dependent on RIG-I if the MEFs were
stimulated with IFNc prior to the infection. In contrast to WT
infection, the IFNb response to virulence plasmid-cured S. flexneri
was not dependent on RIG-I, even in the presence of IFNc
(Fig. 5A), suggesting that either access to the cell cytoplasm (where
RIG-I is located) or another activity of the Type III secretion
system is required for recognition by RIG-I. Collectively, these
findings suggest that in unstimulated MEFs, PRRs other than
RIG-I dominate the innate immune response to S. flexneri, whereas
Figure 5. IFNc potentiates RIG-I-dependent cellular immunity against S. flexneri. (A) Quantification of IFNb secretion by WT and Rig-I
2/2
MEFs. MEFs were infected for 8 hours with WT or virulence plasmid-cured S. flexneri, left uninfected, or transfected for 8 hours with LMW poly (I:C).
Supernatants from the MEFs were then added to L929-ISRE cells, which produce luciferase in response to IFN stimulation. (B) Quantification of Rig-I
expression in uninfected WT MEFs or MEFs infected with WT S. flexneri at an MOI of 1:1 by quantitative RT-PCR. Rig-I levels were normalized to 18S
rRNA levels. All data shown are representative of 2 independent experiments. Where appropriate, significant statistical differences are indicateda s
follows: ns, not significant; *, p,0.05; **,p,0.005 (Student’s t test). Unless indicated otherwise, noted statistical differences are between WT and Rig-
I
2/2 cells for each treatment.
doi:10.1371/journal.ppat.1002809.g005
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the cellular immune response to this bacterium.
To further characterize the RIG-I-dependent immune response
to S. flexneri, we also examined RIG-I expression in uninfected and
infected cells under stimulating and non-stimulating conditions.
Similar to previous reports on other cell types [32,33], we found
that RIG-I is induced 2.5 fold by IFNc in uninfected MEFs
(Fig. 5B). S. flexneri infection alone did not induce significant RIG-I
expression by 5 hpi, but S. flexneri-induced RIG-I expression was
apparent by 10 hpi. Despite the lack of induction by S. flexneri
alone at 5 hpi, IFNc-induced RIG-I expression was significantly
enhanced by the presence of S. flexneri at both 5 and 10 hpi. These
findings demonstrate that IFNc and S. flexneri synergistically induce
RIG-I expression in MEFs, potentially facilitating S. flexneri
recognition during the IFNc response.
RIG-I contains two N-terminal caspase activation and recruit-
ment domains (CARDs), a DExD/h helicase domain, and a C-
terminal repressor domain. In the absence of an activating ligand,
the repressor domain maintains RIG-I in an auto-inhibited state in
the cell cytoplasm [40]. Therefore, RIG-I signaling does not occur
until an activating RNA ligand binds to RIG-I and induces a
conformational change that exposes its CARD domain and allows
for CARD-CARD interactions with its downstream signaling
adaptor MAVS. Due to this mechanism of autoregulation,
overexpression of full-length RIG-I is insufficient to induce
downstream RIG-I signaling [41]. Therefore, although we found
that RIG-I was upregulated in IFNc-activated cells, the upregula-
tion of RIG-I without an activating ligand is unlikely to be
sufficient to induce downstream RIG-I signaling and cannot fully
explain the ability of RIG-I to restrict S. flexneri growth. Rather, the
finding that RIG-I can inhibit S. flexneri growth in the presence of
IFNc suggests that S. flexneri infection provides or generates a
ligand capable of activating RIG-I. Since we found that S. flexneri
activates RIG-I in the presence of IFNc, we began to explore the
possibility that the ability of S. flexneri to activate RIG-I depends
upon the presence of S. flexneri nucleic acids in the host cytoplasm
of activated cells. Although there is debate over the exact nature of
the ligand(s) recognized by RIG-I (reviewed in [42]), this molecule
is largely thought to recognize cytoplasmic short, double-stranded
RNA containing a 59-triphosphate group (thereby avoiding the
recognition of host mRNA, which contains 59 modifications such
as capping). Although RNA species are currently thought to be the
only ligands directly recognized by RIG-I, it has been reported
that foreign dsDNA introduced into the host cytoplasm can
activate RIG-I signaling [43,44]. More recent reports expanded
on these findings to show that RIG-I indirectly recognizes dsDNA
introduced into the host cell cytoplasm through the RNA
polymerase III-dependent transcription of this DNA into an
RNA intermediate that can be recognized by RIG-I [45,46]. The
RNA polymerase III pathway has been shown to be an important
component in the recognition of viruses, L. monocytogenes [47], and
possibly L. pneumophila, despite some controversy [45,48]. To
directly test whether S. flexneri RNA or DNA is sufficient to induce
a RIG-I-dependent cellular response, we extracted S. flexneri
genomic DNA and total RNA from exponential-phase cultures
and then transfected these preparations into WT and Rig-I
2/2
cells. Importantly, the DNA and RNA preparations were treated
with RNase and RNase-free DNase I, respectively, prior to the
transfection to eliminate contaminating nucleic acids. Eight hours
post-transfection, supernatants from these cells were collected and
added to the L929-ISRE IFNb-dependent luciferase reporter cells.
Supernatants from cells transfected with either S. flexneri DNA or
RNA activated WT cells over basal levels (Fig. 6). Interestingly, the
observed activation was dependent on RIG-I in each case,
suggesting that both nucleic acid species have the potential to
activate a RIG-I-dependent response.
Our results suggested that S. flexneri DNA has the potential to
activate the RIG-I pathway. Currently, the only pathway known
to detect bacterial DNA through RIG-I is via the transcription of
cytosolic DNA into a 59-ppp-containing RNA intermediate via the
RNA polymerase III pathway [45,46]. Therefore, we next tested
whether host RNA polymerase III is important for IFNc-mediated
suppression of S. flexneri growth using an RNA polymerase III-
specific inhibitor, ML-60218, described previously [49]. We found
that pre-treatment of MEFs with ML-60218 partially blocked the
ability of IFNc to inhibit S. flexneri growth by 15 hpi (Fig. 7),
potentially suggesting that RNA polymerase III contributes to the
detection and subsequent inhibition of this pathogen. It should be
noted that significant IFNc-dependent killing was still observed in
the presence of ML-60218, and complete reversal of IFNc-
dependent killing by the inhibitor was not apparent. Interestingly,
we did not observe a significant effect of ML-60218 on IFNc-
independent growth restriction, again suggesting that IFNc
enables the functional recognition of intracellular S. flexneri by
the RIG-I/RNA polymerase III pathway to inhibit S. flexneri
growth.
We next wanted to elucidate the downstream mechanism by
which RIG-I enables IFNc-dependent restriction of S. flexneri.
RIG-I signaling not only induces the expression of antimicrobial
ISGs, but also induces the secretion of type I IFNs, which act in an
autocrine manner by binding to the IFN alpha receptor (IFNAR)
and sustaining an antiviral state in the host cell. Therefore, we
sought to determine whether RIG-I-mediated type I IFN
production during infection could explain the role of RIG-I in
the inhibition of S. flexneri growth. First, we examined the ability of
the type I IFN IFNb to inhibit S. flexneri growth in MEFs. At 1 hpi,
similar numbers of CFU were recovered from untreated cells and
from cells stimulated with IFNc or IFNb for 24 hours prior to
infection, demonstrating that there was no difference in the
invasion of S. flexneri into cells under these conditions (Fig. 8A). By
15 hpi, IFNc potently blocked S. flexneri replication by 100-fold, as
Figure 6. S. flexneri nucleic acids are sufficient to induce type I
IFN production via RIG-I. Low molecular weight poly (I:C), extracted
S. flexneri RNA treated with DNase I, or S. flexneri DNA treated with
RNase were transfected into MEFs at 0.4 mg ligand/well. Eight hours
post transfection, supernatants were added to L929-ISRE cells, which
harbor an IFNb-responsive luciferase reporter. Where appropriate,
significant statistical differences are indicated as follows: ns, not
significant; *, p,0.05; **,p,0.005 (Student’s t test). Unless indicated
otherwise, noted statistical differences are between WT and Rig-I
2/2
cells for each treatment.
doi:10.1371/journal.ppat.1002809.g006
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this restriction was much less robust (5-fold growth inhibition),
even at very high concentrations. To definitively determine
whether type I IFN signaling is important for IFNc-mediated S.
flexneri growth restriction, we next examined S. flexneri growth in
MEFs lacking the type I IFN receptor (Ifnar
2/2 MEFs), which are
completely defective in the ability to respond to type I IFNs. IFNc-
stimulated Ifnar
2/2 MEFs were significantly more restrictive for S.
flexneri replication compared to WT MEFs. These findings
demonstrate that while type I IFNs are capable of inhibiting S.
flexneri growth (albeit to a lesser extent compared to IFNc), they are
dispensable for IFNc-mediated growth restriction of this bacteri-
um. Together these findings suggest that the inhibition of S. flexneri
by IFNc occurs due a type I IFN secretion-independent
mechanism following RIG-I signaling.
To further investigate the importance of the IFNc/RIG-I/
MAVS pathway in protection against S. flexneri in vivo, we analyzed
S. flexneri growth in IFNc
2/2, Mavs
2/2,a n dMavs
+/+ mice (Rig-I
2/2
mice are embryonic lethal and were therefore not included). Mice
were infected intranasally with 3610
5 S. flexneri, and the lungs were
harvested at 4 hours and 1, 3, and 5 days post-infection. Mavs
2/2
mice and IFNc
2/2 mice harbored bacterial burdens that were
nearly 1 log greater than those observed in Mavs-sufficient mice by
day 1 post-infection (Fig. 9). Although this difference was not
statistically significant among groups, this trend towards greater
bacterial burden in Mavs
2/2 mice on day 1 post-infection was
consistently observed in 3 independent experiments. Surprisingly,
while the burdens in IFNc
2/2 mice continued to increase through
day 5 (consistent with previous reports, [9]), bacterial burdens in
Mavs
2/2 mice dramatically declined by day 3 by several logs, to
levels below those seen in MAVS-sufficient mice. Although the role
of the MAVS pathway during S. flexneri infection remains to be fully
elucidated, these findings suggest that early during infection the
MAVS pathway plays a small role in the inhibition of S. flexneri
replication in vivo. Collectively, the findings presented here
implicate the RIG-I/MAVS immunosurveillance pathway as an
important component in IFNc-mediated cell autonomous restric-
tion of a cytosolic bacterial pathogen.
Discussion
During an infection, host cells must simultaneously respond to
multiple signals, including both host-derived factors and microbe-
derived factors in order to exert the appropriate immune response.
Here we describe the unexpected mutual requirement for both
host-derived IFNc and infection-dependent stimulation of an
RNA-sensing pathway in order to mediate the inhibition of a
cytosolic bacterial pathogen. For years, cytosolic RNA-sensing
pathways were thought to respond only to viral pathogens. More
recently, the microbes capable of stimulating RNA-sensing
pathways has expanded to include the recognition of bacterial
pathogens as well, including L. pneumophila by RIG-I and MDA5
[48], L. monocytogenes by the RLR laboratory of genetics and
physiology 2 (LGP2) [47], and now also S. flexneri by RIG-I. We
found that RIG-I is key to the recognition and subsequent
elimination of S. flexneri during the IFNc response, potentially
through the recognition of both S. flexneri RNA and an RNA
polymerase III-transcribed RNA intermediate derived from S.
flexneri DNA. Together these findings implicate RNA-sensing
pathways as critical players in the IFNc-mediated cell autonomous
restriction of a cytosolic bacterial pathogen.
Similar studies on other cytoplasmic pathogens have been
performed, although these studies have largely been conducted in
macrophages. In macrophages, IFNc prevents the escape of L.
monocytogenes and F. novicida to the host cytoplasm, while F. tularensis
is not inhibited by IFNc until the bacteria have reached the host
cytoplasm [15,16,17]. Although macrophages are often the
primary mediators of IFNc-inducible killing, complete clearance
of S. flexneri must result from intracellular resistance mechanisms
induced at the site of S. flexneri replication, in the epithelial cell
layer. Therefore, in these studies, we used non-myeloid MEFs as a
model for epithelial cells to understand how IFNc enables the host
to control, and finally clear, an infection with this pathogen. We
found that IFNc inhibits the growth of S. flexneri in MEFs at the
step of cytosolic replication, and not at the earlier stages of entry
and vacuolar escape (Fig. 1). Taken together, these reports
highlight the complexity of the IFNc response in terms of its ability
to recognize and inhibit different pathogens—even different
cytosolic bacterial pathogens—through distinct mechanisms and
at different locations. In the case of S. flexneri, we hypothesize that
the .5 hour delay in the ability of IFNc-activated cells to block S.
flexneri replication corresponds to the recognition of the bacterium
by RIG-I and subsequent induction of antimicrobial mechanisms.
It is possible that during human infection this delay is sufficient for
S. flexneri to begin its cycle of replication and cell-to-cell
dissemination prior to being killed by IFNc-induced mechanisms,
further pushing the host-pathogen balance in favor of the bacteria.
Indeed, IFNc added to cells at the time of the infection had no
effect on S. flexneri growth by 15 hpi (data not shown); it is possible
that S. flexneri is capable of actively interfering with IFNc-mediated
signaling and can establish a productive infection if the cells are
not stimulated prior to the infection. Alternatively, this delay could
be a reflection of the time that it would take for IFNc-dependent
IRF1 induction and subsequent IRF1-, RIG-I- mediated immune
mechanisms to be induced. These possibilities certainly warrant
further investigation.
Synergy between IFNc and PRRs has long been appreciated as
a crucial component of innate immunity. In some cases, IFNc
effectively lowers the concentration of PAMP ligands required to
affect downstream PRR-dependent gene regulation. In other
cases, IFNc priming is absolutely required for downstream PRR-
dependent gene induction [50]. Conversely, PRR signaling can
also enhance IFNc-dependent gene induction. In the case of RIG-
Figure 7. Inhibition of S. flexneri by RIG-I is partially dependent
on the RNA polymerase III pathway. Quantification of S. flexneri
CFU in unstimulated or IFNc-stimulated cells in the presence or absence
of the RNA polymerase III inhibitor ML-60218 (20 mM). Data are
representative of 3 independent experiments. *, p,0.05 (Student’s t
test).
doi:10.1371/journal.ppat.1002809.g007
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expression of the chemokines CXCL9–11, although the functional
consequences of this finding on microbial infection has not been
explored [51,52]. We extended these findings by identifying a role
for RIG-I in mediating IFNc-dependent cell autonomous resis-
tance to a cytosolic bacterial pathogen. The findings presented
here raise two fundamentally important but distinct questions.
How might RIG-I link IFNc signaling to inhibition of S. flexneri
growth? Secondly, how does IFNc potentiate the recognition of S.
flexneri by RIG-I? To first address how RIG-I links IFNc signaling
with inhibition of S. flexneri growth, we considered that RIG-I is
important for the expression of important antimicrobial ISGs
induced by IFNc during S. flexneri infection. In support of this
hypothesis, our preliminary data suggest that ISG expression is
altered by RIG-I downstream of IFNc during infection (data not
shown). Although previous reports have demonstrated that PRRs
can inhibit microbial growth independently of their canonical
downstream signaling adaptors [29], the absolute requirement for
MAVS in the inhibition of S. flexneri by IFNc suggests that RIG-I
functions as a signaling molecule and not through a MAVS-
independent mechanism. Furthermore, our results demonstrate
that the RIG-I-dependent effect occurs in a mechanism indepen-
dent of type I IFN signaling. Therefore, overall we favor a model
in which RIG-I modulates ISG expression or other cell-intrinsic
Figure 8. IFNc-mediated restriction of S. flexneri is not dependent on type I IFN signaling. (A) Quantification of S. flexneri CFU in WT MEFs
stimulated with various concentrations of indicated cytokines. Data are representative of 3 independent experiments. (B) Quantification of S. flexneri
in WT or Ifnar
2/2 MEFs stimulated with IFNc (100 U/ml) for 24 hours or left unstimulated. Significant statistical differences are indicated as follows: ns,
not significant; *, p,0.05; **, p,0.005 (Student’s t test). Unless indicated otherwise, noted statistical differences are between unstimulated and IFNc-
stimulated cells for each condition.
doi:10.1371/journal.ppat.1002809.g008
Figure 9. MAVS appears to control S. flexneri growth at early timepoints but is not required for clearance in vivo. (A) Quantification of S.
flexneri load per gram of lung tissues. IFNc
2/2, Mavs
2/2, and Mavs
+/+ were infected intranasally with 3610
5 CFU S. flexneri. On indicated days post-
infection, lungs were harvested and plated for bacterial CFU enumeration. Statistical differences are indicated as follows:* p,0.05, **, p,0.005 (one-
way ANOVA). (B) Quantification of S. flexneri load per gram of lung tissues over time. Data are representative of 3 independent experiments.
doi:10.1371/journal.ppat.1002809.g009
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growth during the IFNc response. What remains unclear from our
findings is whether RIG-I acts upstream or downstream of IRF1.
An alternative, and equally valid, model to the one presented here
is that the cell upregulates RIG-I upon sensing of S. flexneri
infection, allowing for the activation of RIG-I and subsequent
gene transcription through IRF1, which will have been previously
upregulated by IFNc.
Secondly, to address how IFNc potentiates a RIG-I-dependent
response against S. flexneri, we considered several findings. We
found that RIG-I expression was induced by IFNc but was not
induced by S. flexneri in the absence of IFNc at early timepoints.
Because RIG-I failed to be upregulated by S. flexneri early during
infection, it is possible that greater RIG-I expression in the
presence of IFNc accounts for the ability of RIG-I to ultimately
restrict S. flexneri growth. While upregulation of RIG-I alone may
not fully activate its downstream signaling cascade, the stimulation
of a greater number of RIG-I molecules might be necessary to
overcome a potential evasion of RIG-I signaling by S. flexneri.
However, we also considered an alternative possibility, in which
IFNc-mediated, RIG-I-independent effector mechanisms induce
some amount of lysis or damage to a small number of S. flexneri
early during infection, releasing bacterial nucleic acids into the
cytoplasm that lead to the activation of RIG-I. This model, or an
alternate model requiring more than the simple upregulation of
RIG-I, is more consistent with our findings, since IFNb was a weak
inhibitor of S. flexneri growth (compared to IFNc), despite its
demonstrated ability to upregulate RIG-I expression.
We found that S. flexneri RNA and genomic DNA can each
induce a RIG-I dependent immune response in MEFs (Fig. 6),
however the actual ligand for RIG-I during S. flexneri infection
remains to be identified. Whether S. flexneri DNA or RNA actually
reach the cytoplasm during infection is not known. The finding
that the RNA polymerase III pathway partially contributed to the
inhibitory effect of IFNc on S. flexneri (Fig. 7) suggests that S. flexneri
DNA accesses the cytoplasm and is involved in the IFNc-mediated
immune response during infection. It remains to be determined
whether S. flexneri DNA reaches the cytoplasm by being shed
during normal bacterial replication, bacterial cell lysis, direct
translocation of DNA into the host cytoplasm, or other alternate
mechanisms. The RNA polymerase III pathway appeared to only
partially contribute to the inhibition of S. flexneri replication,
however, supporting the idea that S. flexneri RNA also potentially
activates RIG-I during infection. In support of this hypothesis,
activation of RIG-I signaling by bacterial RNA has previously
been demonstrated for L. pneumophila [48]. Finally, in the case of S.
flexneri infection, we cannot discount the possibility that the
infection induces the recognition of host-derived RIG-I ligands
through the disruption of cellular processes or damage to host
organelles. In fact, in response to viral infections, host nuclease
RNase L can produce small RNAs from host RNA that can serve
as RIG-I ligands [53].
The RNA polymerase III pathway has been shown to be
activated by certain viral and AT-rich DNA [46], however its role
in antibacterial immunity remains to be fully elucidated. Using the
RNA polymerase III inhibitor ML-60218, Chiu, et. al reported
that L. pneumophila activates type I IFN production via the RNA
polymerase III/RIG-I pathway in RAW macrophages, resulting in
inhibition of bacterial growth [45]. A counter report by Monroe,
et al. showed that the RNA polymerase III pathway failed to affect
L. pneumophila replication in bone marrow-derived macrophages
(BMDMs) [48], calling into question the role of the RNA
polymerase III pathway during L. pneumophila infection. More
recently, it was demonstrated that type I IFN production induced
by L. monocytogenes in BMDM is dependent on RNA polymerase III
[47]. Here, we report that the ML-60218 inhibitor partially
relieved IFNc-dependent killing of S. flexneri in MEFs, suggesting
that RNA polymerase III may play a role in this pathway. Despite
this finding, future studies using alternate inhibitors of this
pathway and/or additional techniques will be needed to firmly
establish the role of the RNA polymerase III/RIG-I pathway in
immunity against S. flexneri.
Interestingly, not all PRRs stimulated by S. flexneri exhibited
IFNc-dependent effects on S. flexneri replication. It is possible that
NLR ligands are simply equally available to NLRs in both the
absence and presence of IFNc, whereas RIG-I ligands are
significantly more accessible under IFNc stimulation, as discussed
above. Although MAVS was crucial for S. flexneri restriction by
IFNc, we did observe some IFNc-dependent, RIG-I-independent
effects on growth inhibition (Fig. 4C), suggesting that MDA5 or
other MAVS-dependent host factors might also be involved in S.
flexneri recognition during the IFNc response. Finally, it will be
interesting to investigate the role of MyD88 in the IFNc response
against S. flexneri. One possibility is that TLR2, which we identified
as an IFNc-inducible, IRF1-dependent gene, mediates the
MyD88-dependent effect. However, the strict requirement for
MAVS in the IFNc response suggests an alternate role for MyD88,
such as the MyD88-dependent translocation of IRF1 into the
nucleus, which has been shown to occur in myeloid dendritic cells
[37]. Collectively, we favor a model in which early in infection
NOD-like receptors inhibit the initial growth of S. flexneri in the
epithelial cell layer, but at later times (following the recruitment of
IFNc-producing NK cells and IFNc secretion at the site of
infection) RIG-I becomes a crucial component in the ability of the
host to clear S. flexneri infection.
In vivo, the MAVS pathways appeared to play only a minor role
in inhibiting S. flexneri growth, contributing to protection only at
very early timepoints. One explanation is that IFNc-dependent
control of S. flexneri occurs in non-myeloid cells (such as epithelial
cells) early during infection, while at later timepoints IFNc-
activated macrophages dominate the IFNc-dependent response;
consistent with this hypothesis, we found that neither RIG-I nor
MAVS is important for IFNc-dependent killing of S. flexneri in
primary macrophages (Fig. S2). However, considering that even
unactivated macrophages are non-permissive for S. flexneri
replication, the importance of macrophages in the IFNc response
awaits further investigation. Equally valid is the possibility that
RIG-I/MAVS-dependent effector mechanisms are activated prior
to other intracellular resistance mechanisms, making this pathway
important only until other pathways have been activated, at which
time they become dispensable. This hypothesis is consistent with
the finding that bacterial burdens in Mavs
2/2 mice decreased
dramatically by Day 3, suggesting that other antimicrobial
pathways are in place and that these pathways can compensate
for MAVS in its absence.
Collectively these experiments deepen our understanding of the
many pathways used by host cells to inhibit infections with
cytosolic bacterial pathogens. While the discovery of RIG-I as a
mediator of the antimicrobial host response downstream of IFNc
and IRF1 is exciting, ultimately it will be interesting to identify the
downstream effector mechanisms that inhibit or kill S. flexneri in
host cells. Studies on other cytosolic bacterial pathogens such as L.
monocytogenes have found that IFNc-mediated growth restriction
depends upon the induction of RNS and ROS delivered to
nascent pathogen-containing vacuoles [17,18]. While these
pathways are established resistance mechanisms in macrophages
and other phagocytic cells, these pathways are thought to play a
relatively minor role in IFNc-dependent immunity in non-myeloid
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dent killing of S. flexneri in IFNc-activated MEFs occurs
independently of ROS (unpublished data). Recent advances in
the elucidation and discovery of IFNc-dependent antimicrobial
pathways in non-myeloid cells such as MEFs have led to the
characterization of a multitude of protein families and pathways
capable of exerting cell autonomous resistance against microbial
pathogens, such as the p47 GTPase and p65 GTPase families
(reviewed in [54,55]). Due to the abundance of pathways induced
by IFNc, the microarray experiments described in this paper will
provide a crucial starting point for unraveling the complexity of
the IFNc response against this pathogen. Which of these
described, or previously undescribed, genes are important for
blocking S. flexneri replication in host cells awaits further
investigation.
Materials and Methods
Ethics statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by Harvard’s Animal Care and Use
Committee.
Bacterial strains
Shigella flexneri serovar 2a WT strain 2457T [56] and WT strain
2457T transformed with p-GFPmut2 [57], virulence-plasmid
cured strain BS103 [58], and MGB283 (icsA) on the 2457T
background were described previously. Legionella pneumophila WT
serogroup 1 strain was used [59].
Cell culture
WT and Irf1
2/2 mouse embryonic fibroblasts (MEFs) were
isolated from day 12.5–14.5 embryos. Cell lines that were not
generated inour lab were obtained as follows:Rig-I
2/2 and matched
WTMEFs(L.Gherke,Harvard MedicalSchool);Nod1
2/2,Rip2
2/2
and matched WT MEFs (D. Philpott, University of Toronto);
Myd88
2/2 MEFs (E. Kurt-Jones, University of Massachusetts),
Mavs
2/2 MEFs, WT, Rig-I
2/2,a n dMavs
2/2 immortalized primary
BMMs (J. Kagan, Harvard Medical School); Ifnar
2/2 MEFs (B.
Burleigh, Harvard School of Public Health); L929-ISRE fibroblasts
(B. Beutler, The Scripps Research Institute). Cells were grown in
DMEM (Invitrogen) supplemented with 10% FBS, 16non-essential
amino acids, 16 sodium pyruvate, 100 mM streptomycin, and
100 U/ml penicillin.
IFNc stimulation and in vitro infections
Unless indicated otherwise, 100 U/ml recombinant mouse
IFNc (Chemicon International) was added to cells 24 hours prior
to infection and was maintained throughout the infection. Cells
were infected with S. flexneri by centrifuging exponential phase
bacteria diluted in PBS onto semi-confluent monolayers of cells at
an MOI of 1:1 at 7006g for 10 minutes. The cells were
subsequently incubated for 20 minutes at 37uC and 5% CO2,
washed 3 times with PBS, and resuspended in media containing
gentamicin (25 mg/ml) to kill extracellular bacteria. To assess
intracellular bacterial number, the cells were then incubated for
indicated amounts of time in media containing gentamicin,
washed 3 times with PBS, and lysed in 0.1% sodium deoxycho-
late/PBS. Cell lysates were then plated on tryptic soy agar (TSA)
plates, and CFU were counted after overnight incubation at 37uC.
For L. pneumophila experiments, L. pneumophila were grown on
charcoal yeast extract (CYE) agar for 2 days prior to infections.
Heavy patch cultures were subsequently resuspended in PBS and
centrifuged onto semi-confluent monolayers of cells at an MOI of
30:1 at 7006g for 10 minutes. The cells were subsequently
incubated for 50 minutes at 37uC and 5% CO2, washed 3 times
with PBS, and resuspended in media containing gentamicin
(25 mg/ml) to kill any extracellular bacteria. To assess intracellular
bacterial load, cell monolayers were lysed in sterile water, plated
on CYE agar plates, and incubated at 37uC for 48 hours prior to
CFU enumeration.
Mice and in vivo infections
B6;129-Mavstm1Zjc/J (Mavs
+/2) and B6.129S7-Ifnctm1Ts/J
(IFNc
2/2) mice were obtained from Jackson Laboratories (Bar
Harbor) and bred in specific pathogen-free breeding rooms at
Harvard Medical School. Mavs
+/2 mice were bred with each
other, and Mavs
+/+ and Mavs
2/2 littermates were used in the
experiments. For infections, S. flexneri was subcultured from an
overnight culture to exponential phase (OD600=0.4–0.6), and
diluted with PBS to the appropriate concentration prior to
inoculation. Numbers of bacteria per inoculums were confirmed
by plating serial dilutions of the inoculum. For inoculation, 6–8
week-old mice were lightly sedated with 5% isoflurane (Vedco,
Inc) in oxygen and inoculated by pipetting 40 mL PBS containing
2.5610
5 CFU of bacteria onto the external nares. For quantifi-
cation of bacteria numbers, mice were sacrificed via CO2
inhalation and lungs were excised, homogenized in 2 mL PBS,
serially diluted and plated onto TSA plates containing Congo red
(0.01%). Colonies were counted after incubation at 37uC for 12–
18 hours. The lower limit of detection was 20 CFU.
Immunofluorescence microscopy
Cells were grown and infected on glass cover slips for indicated
amounts of time. Cells were then washed, fixed in 4%
paraformaldehyde for 10 min, washed in PBS, and permeabilized
with 0.1% Triton-X for 10 min. Actin was visualized by staining
with an Alexa Fluor 647-conjugated phalloidin (Invitrogen)
according to the manufacturer’s directions.
Microarrays
MEFs were stimulated with IFNc for 18 hours or left
unstimulated. All cells were subsequently infected at an MOI of
1:1 for 6 hours, a time when the transcription of genes that require
both IFNc and molecular sensing of S. flexneri for their regulation
would be altered. Total RNA was harvested at 6 hpi using the
RNeasy kit (Qiagen) and subsequently treated with DNase I.
Generation of cDNA, cRNA, biotinylation, fragmentation, and
hybridization to Affymetrix mouse whole genome 430 2.0 arrays
were performed at the Harvard Biopolymers Facility. The array
was repeated two times using biological replicates. Data from each
of the 4 samples in one array were first normalized using the MAS
5.0 algorithm using Gene Spring GX software. Next, probe sets in
which 0/4 samples exhibited expression between 20% and 100%
were dropped from further analysis. Out of the 45,101 probe sets
represented on the arrays, 37,569 probe sets had at least one
sample with a value within the cut-off threshold and were kept for
analysis.
Quantitative RT-PCR
Total RNA from MEFs was harvested 6 hpi using the RNeasy
kit (Qiagen) according to the manufacturer’s directions. RNA
samples were treated with DNase I prior to reverse transcription
and amplification with SYBR Green One-Step Quantitative RT-
PCR kit (Qiagen). Transcript levels were normalized to 18S
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TTAGCCCGGACACTTTCTCTGATGG-39 and R, 59-GTCC-
CCTCGAGGGCTGTCAATCTCT-39; Rig-i: F, 59-ATTGTC-
GGCGTCCACAAAG-39 and R, 59-GTGCATCGTTGTATTT-
CCGCA-39; 18S rRNA:F ,5 9-CATTCGAACGTCTGCCCTA-
TC-39 and R, 59-CCTGCTGCCTTCCTTGGA-39.
Transfection of S. flexneri nucleic acids and Type I IFN
secretion assays
Total bacterial genomic DNA was isolated using the DNeasy kit
(Qiagen) in conjunction with RNaseA treatment (Qiagen) at
100 mg/ml for 2 min. Total bacterial RNA was isolated using
RNAprotect Bacterial Reagent (Qiagen) and the RNeasy kit
(Qiagen); isolated RNA was subsequently treated with DNAase I
at 10 U/ml for 10 minutes at 37uC and re-purified using the
RNeasy kit. Transfections of isolated bacterial DNA, RNA, or low
molecular weight poly (I:C) (Invivogen) into MEFs were performed
by mixing indicated nucleic acids with DMEM and Attractene
(Qiagen) to a final ratio of 0.25 mg nucleic acid/ml Attractene and
incubated for 20 minutes. Lipid-ligand complexes were added to
cells at a quantity of 0.4 mg ligand/well of a 24 well plate. Eight
hours post-transfection or post-infection with S. flexneri, superna-
tants were collected and overlaid onto pre-seeded L929-ISRE
cells, which harbor an IFNb-dependent luciferase reporter, for
4 hours. Luciferase expression from L929-ISRE cells was quan-
tified using Bright Glo (Promega) according to the manufacturer’s
directions.
Inhibitors
Where indicated, cycloheximide was added to cells 2 hours
prior to infection at indicated concentrations and was maintained
throughout the experiment. The RNA polymerase III inhibitor
ML-60218 (Calbiochem) was added to cells 2 hours prior to
infection at 20 mM and maintained throughout the experiment.
Statistical analysis
As indicated, a two-tailed Student’s t test for paired samples or a
one-way ANOVA was used to determine statistical significance. A
p value,0.05 was considered statistically significant.
Accession numbers/ID numbers
Microarray data are available in the ArrayExpress database
(www.ebi.ac.uk/arrayexpress) under accession number E-MTAB-
713. Entrez gene ID numbers for genes mentioned in the text are
as follows: Irf1: 16362; Rig-I: 230073; Mavs: 228607; Nod1: 107607;
Rip2: 192656; Myd88: 17874; Ifnar: 15975.
Supporting Information
Figure S1 IFNc-dependent restriction of L. pneumo-
phila occurs independently of RIG-I in MEFs. To
determine if we could observe a requirement for RIG-I during
the IFNc-mediated restriction of a pathogen other than S. flexneri,
we examined the growth of L. pneumophila, a pathogen that is both
restricted by IFNc and activates the RIG-I pathway, in MEFs.
WT and Rig-I
2/2 MEFs were infected at an MOI of 30:1, and the
intracellular growth of L. pneumophila was analyzed at 15 hpi. L.
pneumophila uptake into host cells was equivalent under all
conditions (data not shown). As had been reported previously in
macrophages [48], we observed that WT L. pneumophila replication
was inhibited by RIG-I in unstimulated MEFs and that L.
pneumophila was restricted by IFNc (A). However, normalization of
CFU recovered from IFNc-treated cells against CFU recovered
from untreated cells showed that growth inhibition of this
bacterium by IFNc occurred independently of RIG-I (B). All data
shown are means and standard deviations. Where appropriate,
significant statistical differences are indicated as follows: ns, not
significant; *, p,0.05; **, p,0.005 (Student’s t test). Unless
indicated otherwise, noted statistical differences are between
unstimulated and IFNc-stimulated cells for each condition.
(TIF)
Figure S2 RIG-I and MAVS are dispensable for IFNc-
dependent restriction of S. flexneri in primary BMMs.
Quantification of S. flexneri CFU in WT, Rig
2I2, and Mavs
2/2
BMMs infected at an MOI of 1:1 for indicated amounts of time.
All data shown are means and standard deviations. Where
appropriate, significant statistical differences are indicated as
follows: ns, not significant; *, p,0.05; **, p,0.005 (Student’s t
test). Unless indicated otherwise, noted statistical differences are
between unstimulated and IFNc-stimulated cells for each
condition.
(TIF)
Table S1 List of genes regulated by IFNc during S.
flexneri infection.
(XLS)
Table S2 List of IFNc-regulated, IRF1-dependent genes
during S. flexneri infection.
(XLS)
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